OBJECTIVES
To determine the existence of anti-NF155 antibodies in a subset MS patients.
SAMPLES
CSF
-
(45) 192-01. Isabel M. López.
-
(46) 196-05. Concepción Ciurana.
-
(47) 197-01. Mieria Costa.
-
(48) 197-02. Michael Labatzki.
-
(49) 197-05. Víctor Pérez.
-
(50) 197-19. Olga Teixidó.
-
(51) 198-11. David Poca.
-
(52) 199-09. Beatriz Núñez.
-
(53) 201-10. Pascual Meléndez.
-
(54) 201-14. Joan Bernal.
Serum
-
109
-
111
-
114
-
115
-
171
-
214
-
215
-
221
-
Negative control (Edu serum)
-
Positive control (15-195)
MATERIALS
-
Human NF155-transfected HEKs 293 grown in coverslips. Fixed with PFA 4% and blocked with GOAT serum 5% in PBS.
-
PBS.
-
Blocking: GOAT 5% in PBS.
-
Patient’s CSF diluted 1/1 with GOAT 5% in PBS. Control sera diluted 1/100 with GOAT 5% in PBS.
-
Primary Ab: Chicken anti-NF155: AF3235 (1/1000).
-
Secondary Abs: GAH 594 (1/1000) + GAC 488 (1/1000).
-
Vectashield mounting medium.
PROCEDURE
-
NF155-transfected HEKs were grown and fixed on coverslips and frozen at -80ºC. They where thawed before the ICC with Goat Serum 5%.
-
Added patient’s CSF at 1/1 dilution in Goat Serum 5% and incubated 1h at RT. Sera were diluted at 1/100.
-
Washed 3 times with water.
-
Added primary commercial anti-NF155 Ab: AF3235 at 1/1000 dilution and incubated 1h at RT.
-
Washed 3 times with water.
-
Added secondary Abs: GAH 594 and GAC 488 1/1000 each and incubated 1h at RT.
-
Washed 3 times with water.
-
Added Vectashield mounting medium and put onto microscope slides.
-
The slides were observed with a fluorescense microscope to determine wether or not the patients’ CSF presented anti-NF155 antibodies.
RESULTS
-
Negative.
-
Negative.
-
Negative.
-
Negative.
-
Negative.
-
Negative.
-
Negative.
-
Negative.
-
Negative.
-
Negative.
-
Non-visible or non-tinted cells.
-
Negative.
-
Negative.
-
Negative.
-
Non-visible or non-tinted cells.
-
Negative.
-
Negative.
-
Negative.
-
Negative.
-
Positive.